Lisinopril vs Rituximab
Lisinopril vs Rituximab: Overview
This comparison examines the pharmacological differences between Lisinopril and Rituximab.
Mechanism of Action
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Lisinopril — 12 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Lisinopril — C21H31N3O5.
Molecular Weight: Lisinopril — 405.4900 g/mol.
Type: Lisinopril — Small molecule; Rituximab — Antibody.